BRIEF REVIEW ON MULTIPLE SCLEROSIS

Journal Title: World Journal of Pharmaceutical Research - Year 2017, Vol 6, Issue 11

Abstract

There is no known cure for multiple sclerosis. Treatments attempt to improve function after an attack and prevent new attacks. Medications used to treat MS, while modestly effective, can have side effects and be poorly tolerated Multiple sclerosis usually starts with an acute episode of neurological disturbance, termed a 'clinically isolated syndrome', followed by an illness phase punctuated by relapses and remissions which may transition after 10 years to a phase of progressive accumulation of disability without relapses. Fifteen to 20% of patients will have a progressive course from the onset. There is significant interpatient variability in prognosis. The main diagnostic criteria are clinical, supported by investigations including magnetic resonance imaging and lumbar puncture and evoked potentials. First line disease modifying agents for relapsing remitting multiple sclerosis include interferon-ß and glatiramer. First line treatment for relapses is usually intravenous methylprednisolone for 3 days. Troublesome symptoms may include spasticity, parasthesias, tremor, erectile dysfunction, depression and anxiety, fatigue and pain. After excluding differential diagnoses, symptomatic management includes pharmacological agents, allied health consultation and continence strategies. Although pregnancy reduces disease activity, there is a higher risk of relapse in the postpartum period.

Authors and Affiliations

Deepak Bhatt

Keywords

.

Related Articles

SIMPLE CLINICAL REVIEW ABOUT THE ASSOCIATION OF BARIATRIC SURGERY WITH DEVELOPMENT OF CHOLELITHIASIS

Background: Significant research papers were published to assess the relation between rapid weight loss and the development of cholelithiasis and the risk factors behind it. Assessment of cholelithiasis development after...

A CRITICAL ANALYSIS OF AYURVEDIC HERBS USED IN VAATSHLESHAMIK JWARA W.S.R. TO SWINE FLU

Major concept of aurveda is prevention and cure of a disease by natural ways. In Ayurveda it is said that pragyapradh is the main cause of janpadodhwans (epidemic/pandemic disease). In August 2010, the World Health Organ...

EBOLA VIRUS DISEASE OUTBREAKS AS GLOBAL DISASTERS

Ebola virus disease (EVD) is caused by Ebola viruses (EBOV), members of the group of hemorrhagic fevers and it is one of the most dangerous infection diseases with mortality rates up to 90%. Ebola was firstly described i...

CORRELATION OF REGULATORY AFFAIRS OFFICER WITH DIFFERENT DEPARTMENT OF PHARMACEUTICAL INDUSTRY IN INDIA AND IMPACT OF GST

Drug Regulatory Affair (DRA) is an important part of the organizational structure of Pharmaceutical companies. Now days it’s necessary to have DRA department in companies for fast growth and development of the company. T...

PREVALENCE OF MENTAL DISTRESS AMONG UNDEGRADUATE MEDICAL STUDENTS AT MAJMAAH UNIVERSITY, KINGDOM OF SAUDI ARABIA

Background: Medical Education and Medical Profession are among the most challenging and stressful ones. It also poses many new, challenging and potentially threatening situational demands on the incoming students. Anxiet...

Download PDF file
  • EP ID EP618243
  • DOI -
  • Views 180
  • Downloads 0

How To Cite

Deepak Bhatt (2017). BRIEF REVIEW ON MULTIPLE SCLEROSIS. World Journal of Pharmaceutical Research, 6(11), 180-194. https://www.europub.co.uk/articles/-A-618243